How much does zotuximab cost? Are the prices different for different specifications and regions?

Zolbetuximab is a monoclonal antibody used to treat gastric cancer. Its original drug has been launched in China, but due to its short time on the market, the specific price of the drug has not yet been fully determined. In addition, the drug is currently not included in medical insurance, so patients need to consult the relevant medical institutions or pharmacies to learn the latest market price when purchasing. The specific price may fluctuate with market changes, especially in the early stages of drug supply, the price range may be large.

The price of zotuximab in China has not yet been fully disclosed because the drug has just been launched and has not yet been included in medical insurance. The price may be affected by market supply, government policies and pharmacy pricing strategies. According to current industry information and feedback from some patients, The price may be higher, and patients need to consult specific medical institutions or pharmacies in advance. The specific selling price will be affected by factors such as region, purchasing channel, and whether drug subsidies are provided, so it is very important to understand the relevant information before purchasing.

In overseas markets, the price of zotuximab has gradually stabilized. The common specification is 100mg. For example, in the European and Japanese markets, the price of zotuximab is about 7000 more than RMB per box. The price will be affected by exchange rate fluctuations and pricing strategies in different regions. In the European market, the selling price may be higher due to import taxes, transportation costs and regional differences in medicines. In the Japanese market, as local drug pricing is usually relatively stable, prices may be slightly lower than in other international markets.

There are currently no generic drugs of zotuximab on the market This leaves patients with the only option of purchasing the original drug. Since zotuximab has not yet entered the generic phase globally, the only option faced by patients is often the originator drug, which may result in higher prices. However, as time goes by, more countries and regions may produce generic versions of the drug, and the emergence of generic drugs will exert certain competitive pressure on drug prices.

The price of zotuximab varies significantly in different countries and regions and is affected by market access, exchange rate fluctuations and local drug pricing policies. For patients, if domestic drug prices are high or unaffordable, considering purchasing drugs overseas may be an option. Although there are additional costs such as tariffs and transportation fees to consider when purchasing imported drugs, it is still an avenue worth considering if you can ensure that the source of the drugs is formal and meets local drug safety standards. In addition, patients should also pay close attention to whether there is a drug reimbursement policy and whether there are preferential plans or philanthropic funding for which to apply.